Finance

Lists
Why is 300485 up 2.27%?
Dive Deeper
300485:SHE
Beijing Science Sun Pharmaceutical CoLtd
CNÂ¥8.57
+2.27%
(+0.19) 1D
Oct 9, 3:04:52 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300485...
Open
CNÂ¥8.31
High
CNÂ¥8.62
Low
CNÂ¥8.15
Mkt. cap
4.04B
Avg. vol.
6.68M
Volume
4.80M
Dividend
0.35%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
May 27, 2026
52-wk high
CNÂ¥13.80
52-wk low
CNÂ¥7.77
EPS
-CNÂ¥0.37
Shares outstanding
481.67M
No. of employees
489
Open
CNÂ¥8.31
High
CNÂ¥8.62
Low
CNÂ¥8.15
Mkt. cap
4.04B
Avg. vol.
6.68M
Volume
4.80M
Dividend
0.35%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
May 27, 2026
52-wk high
CNÂ¥13.80
52-wk low
CNÂ¥7.77
EPS
-CNÂ¥0.37
Shares outstanding
481.67M
No. of employees
489
News stories
From web sources and news partners
About Beijing Science Sun Pharmaceutical CoLtd
CEO-
Employees489
FoundedMay 20, 1999
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
111.83M
96.09M
90.44M
90.29M
Cost of goods sold
36.99M
41.28M
28.84M
29.27M
Cost of revenue
36.99M
41.28M
28.84M
29.27M
Research and development expenses
21.07M
21.11M
8.33M
21.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53.16M
54.89M
43.44M
49.52M
Operating expense
74.27M
77.76M
52.07M
72.65M
Total operating expenses
111.26M
119.05M
80.91M
101.92M
Operating income
562.26K
-22.96M
9.53M
-11.64M
Other non operating income
-72.37K
30.17K
-9.21K
-7.68K
EBT including unusual items
7.54M
-46.89M
4.44M
-176.06M
EBT excluding unusual items
13.15M
-13.68M
11.47M
-13.69M
Income tax expense
4.74M
-6.13M
627.08K
-26.34M
Effective tax rate
62.91%
13.07%
14.12%
14.96%
Other operating expenses
554.25K
3.32M
1.05M
3.14M
Net income
4.07M
-37.29M
4.66M
-148.34M
Net profit margin
3.64%
-38.81%
5.16%
-164.30%
Earnings per share
-
-
-
-
Interest and investment income
12.66M
9.34M
2.02M
-
Interest expense
-
-454.54K
-67.50K
-2.29M
Net interest expenses
12.66M
8.89M
1.95M
-2.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
12.27M
-11.23M
21.25M
-361.07K
Gain or loss from assets sale
111.88K
-111.88K
-
-
AI content may include mistakes. Learn more
Google apps